ESR1 and neoplasm: For our analysis, we select the 10 most differentially expressed genes between ‘pathologic complete response’ (34 patients) and ‘residual disease’ (99 patients), and the categorical variables estrogen receptor status, progesterone receptor status, tumor grade and molecular subclass.